journal article·2022-07-19Open access

Multifactorial Model Based on DWI-Radiomics to Determine HPV Status in Oropharyngeal Squamous Cell Carcinoma

Simona Marzi, Francesca Piludu, Ilaria Avanzolini, Valerio Muneroni, Giuseppe Sanguineti, Alessia Farneti, Pasqualina D’Urso, Maria Benevolo, Francesca Rollo, Renato Covello, Francesco Mazzola, Antonello Vidiri

Applied Sciences· Volume 12· Issue 14

Abstract

Background: Oropharyngeal squamous cell carcinoma (OPSCC) associated with human papillomavirus (HPV) has higher rates of locoregional control and a better prognosis than HPV-negative OPSCC. These differences are due to some unique biological characteristics that are also visible through advanced imaging modalities. We investigated the ability of a multifactorial model based on both clinical factors and diffusion-weighted imaging (DWI) to determine the HPV status in OPSCC. Methods: The apparent diffusion coefficient (ADC) and the perfusion-free tissue diffusion coefficient D were derived from DWI, both in the primary tumor (PT) and lymph node (LN). First- and second-order radiomic features were extracted from ADC and D maps. Different families of machine learning (ML) algorithms were trained on our dataset using five-fold cross-validation. Results: A cohort of 144 patients was evaluated retrospectively, which was divided into a training set (n = 95) and a validation set (n = 49). The 50th percentile of DPT, the inverse difference moment of ADCLN, smoke habits, and tumor subsite (tonsil versus base of the tongue) were the most relevant predictors. Conclusions: DWI-based radiomics, together with patient-related parameters, allowed us to obtain good diagnostic accuracies in differentiating HPV-positive from HPV-negative patients. A substantial decrease in predictive power was observed in the validation cohort, underscoring the need for further analyses on a larger sample size.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Radiomics and Machine Learning in Medical Imaging · MRI in cancer diagnosis · Head and Neck Cancer Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medical Physics Laboratory, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy

Radiology and Diagnostic Imaging Department, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy

Scuola di Specializzazione in Radiodiagnostica, Sapienza Università di Roma—Policlinico Umberto I, Viale Regina Elena 324, 00161 Rome, Italy

Department of Radiotherapy, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy

Pathology Department, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy

Otolaryngology & Head and Neck Surgery, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy

Funding

Italian Association for Cancer Research

References (41)

Show source-provided references
1. Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies10.1016/j.semradonc.2021.02.009 ↗
2. O’Sullivan, B., Lydiatt, W.M., Haughey, B.H., Brandwein-Gensler, M., Glastonbury, C.M., Shah, J.P., Amin, M.B., Edge, S., and Greene, F. (2017). HPV-mediated (p16+) oropharyngeal cancer. AJCC Cancer Staging Manual, Springer. [8th ed.].
3. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: A two-tier approach10.1038/s41416-019-0414-9 ↗
4. Advances in Diagnosis and Multi-disciplinary Management of Oro-pharyngeal Squamous Cell Carci-noma
5. Imaging at Diagnosis Impacts Cancer Specific Survival of Patients with Cancer of the Oropharynx10.1002/cncr.32148 ↗
6. Evaluation of head and neck tumors with functional MR imaging10.1016/j.mric.2015.08.011 ↗
7. Machine Learning for Medical Imaging10.1148/rg.2017160130 ↗
8. Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers10.3389/fonc.2019.00174 ↗
9. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma10.1016/j.ejrad.2019.06.019 ↗
10. PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma10.1007/s00259-020-04839-2 ↗
11. Radiomic biomarkers for head and neck squamous cell carcinoma10.1007/s00066-020-01638-4 ↗
12. Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology10.1016/j.semradonc.2021.05.001 ↗
13. Radiomic analysis in prediction of Human Papilloma Virus status
14. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: A multicenter study10.1259/bjr.20170498 ↗
15. Application of radiomics for the prediction of HPV status for patients with head and neck cancers10.1002/mp.13977 ↗
16. Radiomic Features Associated With HPV Status on Pretreatment Computed Tomography in Oropharyngeal Squamous Cell Carcinoma Inform Clinical Prognosis10.3389/fonc.2021.744250 ↗
17. Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma10.3174/ajnr.A4271 ↗
18. Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma10.1007/s00405-013-2641-7 ↗
19. Oropharyngeal squamous cell carcinoma: Radiomic machine-learning classifiers from multiparametric MR images for determination of HPV infection status10.1038/s41598-020-74479-x ↗
20. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas10.1002/hed.24051 ↗
21. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer10.1038/bjc.2013.639 ↗
22. Double Positivity for HPV-DNA/p16(Ink4a) is the Biomarker with Strongest Diagnostic Accuracy and Prognostic Value for Human Papillomavirus Related Oropharyngeal Cancer Patients10.1016/j.oraloncology.2018.01.010 ↗
23. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging10.1148/radiology.168.2.3393671 ↗
24. 3D Slicer as an image computing platform for the Quantitative Imaging Network10.1016/j.mri.2012.05.001 ↗
25. Technical Note: An IBEX adaption toward image biomarker standardization10.1002/mp.13956 ↗
26. Ibex: An open infrastructure software platform to facilitate collaborative work in radiomics10.1118/1.4908210 ↗
27. Zwanenburg, A., Leger, S., Vallières, M., and Löck, S. (2020). Image biomarker standardisation initiative. arXiv.
28. Reliability of CT radiomic features reflecting tumour heterogeneity according to image quality and image processing parameters10.1038/s41598-020-60868-9 ↗
29. Harmonization of multi-site diffusion tensor imaging data10.1016/j.neuroimage.2017.08.047 ↗
30. Standardization of imaging features for radiomics analysis10.2152/jmi.66.35 ↗
31. Minimum redundancy feature selection from microarray gene expression data10.1142/S0219720005001004 ↗
32. SMOTE: Synthetic minority over-sampling technique10.1613/jair.953 ↗
33. Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer10.1002/hed.26505 ↗
34. Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma10.3174/ajnr.A5792 ↗
35. Intravoxel incoherent motion diffusion-weighted imaging for oropharyngeal squamous cell carcinoma: Correlation with human papillomavirus Status10.1016/j.ejrad.2019.08.009 ↗
36. Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation10.1007/s00330-020-07163-3 ↗
37. Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology10.3174/ajnr.A5370 ↗
38. Intravoxel incoherent motion magnetic resonance imaging in head and neck cancer: A systematic review of the diagnostic and prognostic value10.1016/j.oraloncology.2017.03.016 ↗
39. Intraindividual homogeneity of 18F-FDG PET/CT parameters in HPV-positive OPSCC10.1016/j.oraloncology.2017.08.019 ↗
40. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and elaboration10.7326/M14-0698 ↗
41. Epidemiology of HPV Related Malignancies10.1016/j.semradonc.2021.04.001 ↗